Novo Nordisk A/S (NVO)

Orchard Therapeutics Employees

As of December 31, 2024, Novo Nordisk had 77,349 total employees, including 76,302 full-time and 1,047 part-time employees. The number of employees increased by 13,030 or 20.26% compared to the previous year.

• Employees: 77,349
• Change (1Y): 13,030
• Growth (1Y): 20.26%
• Revenue / Employee: $634,901
• Profits / Employee: $226,061
• Market Cap: 224.34B

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	77,349	13,030	20.26%
Dec 31, 2023	64,319	9,134	16.55%
Dec 31, 2022	55,185	6,707	13.84%
Dec 31, 2021	48,478	3,155	6.96%
Dec 31, 2020	45,323	2,065	4.77%
Dec 31, 2019	43,258	56	0.13%
Dec 31, 2018	43,202	520	1.22%
Dec 31, 2017	42,682	711	1.69%
Dec 31, 2016	41,971	1,333	3.28%
Dec 31, 2015	40,638	-319	-0.78%
Dec 31, 2014	40,957	2,521	6.56%
Dec 31, 2013	38,436	3,705	10.67%
Dec 31, 2012	34,731	2,099	6.43%
Dec 31, 2011	32,632	2,149	7.05%
Dec 31, 2010	30,483	1,154	3.93%
Dec 31, 2009	29,329	2,754	10.36%
Dec 31, 2008	26,575	1,059	4.15%
Dec 31, 2007	25,516	1,903	8.06%
Dec 31, 2006	23,613	1,153	5.13%
Dec 31, 2005	22,460	1,735	8.37%
Dec 31, 2004	20,725	1,969	10.50%
Dec 31, 2003	18,756	751	4.17%
Dec 31, 2002	18,005	1,864	11.55%
Dec 31, 2001	16,141	2,389	17.37%
Dec 31, 2000	13,752	1,758	14.66%
Dec 31, 1999	11,994	345	2.96%
Dec 31, 1998	11,649	-	-

Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.